Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V.
Hertogs K, Bloor S, De Vroey V, van Den Eynde C, Dehertogh P, van Cauwenberge A, Stürmer M, Alcorn T, Wegner S, van Houtte M, Miller V, Larder BA. Hertogs K, et al. Among authors: sturmer m. Antimicrob Agents Chemother. 2000 Mar;44(3):568-73. doi: 10.1128/AAC.44.3.568-573.2000. Antimicrob Agents Chemother. 2000. PMID: 10681319 Free PMC article.
Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1: interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214.
Stürmer M, Staszewski S, Doerr HW, Larder B, Bloor S, Hertogs K. Stürmer M, et al. Antimicrob Agents Chemother. 2003 Jan;47(1):54-61. doi: 10.1128/AAC.47.1.54-61.2003. Antimicrob Agents Chemother. 2003. PMID: 12499169 Free PMC article.
Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride.
Miller V, de Béthune MP, Kober A, Stürmer M, Hertogs K, Pauwels R, Stoffels P, Staszewski S. Miller V, et al. Among authors: sturmer m. Antimicrob Agents Chemother. 1998 Dec;42(12):3123-9. doi: 10.1128/AAC.42.12.3123. Antimicrob Agents Chemother. 1998. PMID: 9835502 Free PMC article. Clinical Trial.
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.
Larder BA, Bloor S, Kemp SD, Hertogs K, Desmet RL, Miller V, Sturmer M, Staszewski S, Ren J, Stammers DK, Stuart DI, Pauwels R. Larder BA, et al. Among authors: sturmer m. Antimicrob Agents Chemother. 1999 Aug;43(8):1961-7. doi: 10.1128/AAC.43.8.1961. Antimicrob Agents Chemother. 1999. PMID: 10428920 Free PMC article.
Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1.
Lötsch J, Harder S, Stürmer M, Doerr HW, Geisslinger G, Staszewski S, von Hentig N. Lötsch J, et al. Among authors: sturmer m. Antimicrob Agents Chemother. 2007 Sep;51(9):3264-72. doi: 10.1128/AAC.00036-07. Epub 2007 Jun 18. Antimicrob Agents Chemother. 2007. PMID: 17576836 Free PMC article.
122 results